Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming Pang

Showing results (131-140 of 137) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 137 results.
Chinese Medical Journal|August 1, 2015
Outcomes of Adults with Acute Lymphoblastic Leukemia After Autologous Hematopoietic Stem Cell Transplantation and the Significance of Pretransplantation Minimal Residual Disease: Analysis from a Single Center of ChinaZhe Ding, Ming-Zhe Han, Shu-Lian Chen, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 17, 2012
[Risk factors and prognosis of invasive fungal infections in patients with hematological diseases]A-Xia Song, Yong Huang, Dong-Lin Yang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 9, 2019
Conditioning Regimen of 5-Day Decitabine Administration for Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome and Myeloproliferative NeoplasmsYi-Geng Cao, Yi He, Su-Dong Zhang, et al.
Cancer Biology & Therapy|October 13, 2018
Inhibiting crosstalk between MET signaling and mitochondrial dynamics and morphology: a novel therapeutic approach for lung cancer and mesotheliomaJiale Wang, Tamara Mirzapoiazova, Yi-Hung Carol Tan, et al.
Oncogenesis|September 6, 2019
EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesotheliomaYi-Hung Carol Tan, Saumya Srivastava, Brian M Won, et al.
Oncogene|June 19, 2026
The splicing factor hnRNPA1 promotes osimertinib resistance in lung adenocarcinoma by regulating NEDD4L alternative splicingYanfeng Liang, Yudong Guo, Xiaobi Huang, et al.
Pharmacogenomics|June 9, 2017
Tailoring of recommendations to reduce serious cutaneous adverse drug reactions: a pharmacogenomics approachWei Chuen Tan-Koi, Cynthia Sung, Yong Yeow Chong, et al.
Pageof 14

Showing results (131-140 of 137) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 137 results.
Chinese Medical Journal|August 1, 2015
Outcomes of Adults with Acute Lymphoblastic Leukemia After Autologous Hematopoietic Stem Cell Transplantation and the Significance of Pretransplantation Minimal Residual Disease: Analysis from a Single Center of ChinaZhe Ding, Ming-Zhe Han, Shu-Lian Chen, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 17, 2012
[Risk factors and prognosis of invasive fungal infections in patients with hematological diseases]A-Xia Song, Yong Huang, Dong-Lin Yang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 9, 2019
Conditioning Regimen of 5-Day Decitabine Administration for Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome and Myeloproliferative NeoplasmsYi-Geng Cao, Yi He, Su-Dong Zhang, et al.
Cancer Biology & Therapy|October 13, 2018
Inhibiting crosstalk between MET signaling and mitochondrial dynamics and morphology: a novel therapeutic approach for lung cancer and mesotheliomaJiale Wang, Tamara Mirzapoiazova, Yi-Hung Carol Tan, et al.
Oncogenesis|September 6, 2019
EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesotheliomaYi-Hung Carol Tan, Saumya Srivastava, Brian M Won, et al.
Oncogene|June 19, 2026
The splicing factor hnRNPA1 promotes osimertinib resistance in lung adenocarcinoma by regulating NEDD4L alternative splicingYanfeng Liang, Yudong Guo, Xiaobi Huang, et al.
Pharmacogenomics|June 9, 2017
Tailoring of recommendations to reduce serious cutaneous adverse drug reactions: a pharmacogenomics approachWei Chuen Tan-Koi, Cynthia Sung, Yong Yeow Chong, et al.
Pageof 14